Myomo (MYO) Share-based Compensation (2016 - 2025)
Myomo (MYO) reported Share-based Compensation of $583991.0 for Q3 2025, up 80.14% on a YoY basis from $324185.0 in Q3 2024, and up 47.89% quarter-over-quarter from $394889.0 in Q2 2025.
Myomo (MYO) Share-based Compensation (2016 - 2025) Analysis & Trends
Myomo has reported Share-based Compensation for 10 years, with the latest figure at $583991.0 in Q3 2025.
- For the quarter ending Q3 2025, Share-based Compensation rose 80.14% year-over-year to $583991.0; the trailing twelve-month figure through Sep 2025 stood at $1.8 million (up 107.62% YoY), and the FY2024 full-year result was $874438.0, down 21.62% from the prior year.
- Share-based Compensation for Q3 2025 stood at $583991.0, up from $394889.0 in the prior quarter.
- The five-year high for Share-based Compensation was $583991.0 in Q3 2025, with the low at -$91893.0 in Q2 2024.
- Historically, Share-based Compensation has averaged $305052.4 across 5 years, with a median of $320288.0 in 2024.
- Annual changes were most pronounced in 2024 — Share-based Compensation sank 132.81% — and 2025, when it soared 529.73%.
- Myomo's Share-based Compensation stood at $265362.0 in 2021, then gained by 3.02% to $273368.0 in 2022, then increased by 22.21% to $334089.0 in 2023, then fell by 3.66% to $321858.0 in 2024, then surged by 81.44% to $583991.0 in 2025.
- The last three Share-based Compensation figures came in at $583991.0 (Q3 2025), $394889.0 (Q2 2025), and $540204.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 583,991.00 |
| Sep 30, 2025 | 583,991.00 |
| Jun 30, 2025 | 394,889.00 |
| Jun 30, 2025 | 394,889.00 |
| Mar 31, 2025 | 540,204.00 |
| Mar 31, 2025 | 540,204.00 |
| Dec 31, 2024 | 321,858.00 |
| Dec 31, 2024 | 321,858.00 |
| Sep 30, 2024 | 324,185.00 |
| Sep 30, 2024 | 324,185.00 |
| Jun 30, 2024 | -91,893.00 |
| Jun 30, 2024 | -91,893.00 |
| Mar 31, 2024 | 320,288.00 |
| Mar 31, 2024 | 320,288.00 |
| Dec 31, 2023 | 334,089.00 |
| Dec 31, 2023 | 334,089.00 |
| Sep 30, 2023 | 330,394.00 |
| Sep 30, 2023 | 330,394.00 |
| Jun 30, 2023 | 280,061.00 |
| Jun 30, 2023 | 280,061.00 |